Alexandria Real Estate Equities, Inc.

    ARE ·NYSE ·Real Estate Investment Trusts ·Inc. in MD
    Loading chart...

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    From 10-Q filed 2026-04-27 (period ending 2026-03-31).

    45
    ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    Forward-looking statements
    Certain information and statements included in this quarterly report on Form 10-Q, including, without limitation, statements
    containing the words “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,”
    “seeks,” “should,” “targets,” or “will,” or the negative of those words or similar words, constitute “forward-looking statements” within the
    meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
    amended. Forward-looking statements involve inherent risks and uncertainties regarding events, conditions, and financial trends that
    may affect our future plans of operations, business and financial strategy, results of operations, and financial position. A number of
    important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking
    statements, including, but not limited to, the following:
    Operating factors, such as a failure to operate our business successfully in comparison to market expectations or in
    comparison to our competitors, our inability to obtain capital when desired or refinance debt maturities when desired, and/
    or a failure to maintain our status as a REIT for federal tax purposes;
    Market and industry factors, such as adverse developments concerning the life science industry and/or our tenants;
    Government factors, such as any unfavorable effects resulting from federal, state, local, and/or foreign government
    policies, laws, and/or funding levels;
    Global factors, such as negative economic, social, political, financial, credit market, banking conditions, and/or regional
    armed hostilities; and
    Other factors, such as climate change, cyber intrusions, and/or changes in laws, regulations, and financial accounting
    standards.
    This list of risks and uncertainties is not exhaustive. Additional information regarding risk factors that may affect us is included
    under Part I; “Item 1A. Risk factors”; and “Item 7. Management’s discussion and analysis of financial condition and results of
    operations” in our annual report on Form 10-K for the year ended December 31, 2025 and under respective sections in this quarterly
    report on Form 10-Q. Readers of this quarterly report on Form 10-Q should also read our other documents filed publicly with the SEC
    for further discussion regarding such factors.
    46
    Overview
    We are a Maryland corporation formed in October 1994 that has elected to be taxed as a REIT for federal income tax
    purposes. Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science
    REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate
    niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in
    AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland,
    Research Triangle, and New York City. As of March 31, 2026, Alexandria has a total market capitalization of $20.44 billion and an asset
    base that includes 35.8 million RSF of operating properties and 3.4 million RSF of Class A/A+ properties undergoing construction.
    We develop dynamic Megacampus ecosystems that enable and inspire some of the world’s most brilliant minds and innovative
    companies to create life-changing scientific and technological innovations. We believe in the utmost professionalism, humility, and
    teamwork. Our tenants include multinational pharmaceutical companies; life science product, service, and device companies; public
    and private biotechnology companies; advanced technologies companies; biomedical institutions; U.S. government institutions; and
    others. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and
    collaborative Megacampus environments that enhance our tenants’ ability to successfully recruit and retain world-class talent and
    inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science
    companies through our venture capital platform.
    As of March 31, 2026:
    Investment-grade or publicly traded large cap tenants represented 55% of our annual rental revenue;
    Approximately 97% of our leases (on an annual rental revenue basis) contained effective annual rent escalations
    approximating 3% that were either fixed or indexed based on a consumer price index or other index;
    Approximately 91% of our leases (on an annual rental revenue basis) were triple net leases, which require tenants to pay
    substantially all real estate taxes, insurance, utilities, repairs and maintenance, common area expenses, and other
    operating expenses (including increases thereto) in addition to base rent;
    Approximately 92% of our leases (on an annual rental revenue basis) provided for the recapture of capital expenditures
    (such as HVAC maintenance and/or replacement, roof replacement, and parking lot resurfacing) that we believe would
    typically be borne by the landlord in traditional office leases; and
    78% of our leasing activity during the last twelve months was generated from our existing tenant base.
    A key element of our business and financial strategy is our unique focus on Class A/A+ properties primarily located in
    collaborative Megacampus ecosystems in AAA life science innovation clusters. Our Megacampus ecosystems are designed for
    optionality and scalability, offering our tenants a clear path to address their growth requirements, including through our future
    developments and redevelopments. Strategically located near top academic and medical research institutions and equipped with
    curated amenities and services and convenient access to transit, our Megacampus ecosystems are designed to support our tenants in
    attracting and retaining top talent and in meeting our tenants’ growth needs, which we believe is a key driver of tenant demand for our
    properties. Our strategy also includes drawing upon our deep, broad, and long-standing real estate and life science industry
    relationships in order to retain tenants, identify and attract new and leading tenants, and source additional real estate.
    47
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
    Executive summary
    Operating results
    Three Months Ended March 31,
    2026
    2025
    Net income (loss) attributable to Alexandria’s common stockholders – diluted:
    In millions
    $358.9
    $(11.6)
    Per share
    $2.10
    $(0.07)
    Funds from operations attributable to Alexandria’s common stockholders – diluted, as
    adjusted:
    In millions
    $295.9
    $392.0
    Per share
    $1.73
    $2.30
    For additional information, refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria
    Real Estate Equities, Inc.’s common stockholders” under “Definitions and reconciliations.”
    A best-in-class REIT with a high-quality, diverse tenant base, strong margins, and long lease terms
    (As of March 31, 2026, unless stated otherwise)
    Occupancy of operating properties
    87.7%
    Percentage of total annual rental revenue in effect from Megacampus platform
    78%
    Percentage of total annual rental revenue in effect from investment-grade or publicly traded large cap tenants
    55%
    Adjusted EBITDA margin for the three months ended March 31, 2026
    66%
    Percentage of leases containing annual rent escalations
    97%
    Weighted-average remaining lease term:
    Top 20 tenants
    9.9
    years
    All tenants
    7.5
    years
    Strong tenant collections(1):
    Rents and receivables for the three months ended March 31, 2026, collected as of the date of this report
    99.9%
    (1)Refer to “Tenant Collections” under “Definitions and reconciliations” for additional details.
    Strong and flexible balance sheet with significant liquidity; top 15% credit rating ranking among all publicly traded U.S. REITs
    Net debt and preferred stock to Adjusted EBITDA of 6.8x and fixed-charge coverage ratio of 3.4x for the three months ended
    March 31, 2026 annualized, with targets for the three months ending December 31, 2026 annualized of 5.6x-6.2x and
    3.6x-4.1x, respectively.
    We expect improvement in our quarter annualized net debt and preferred stock to Adjusted EBITDA ratio in the second
    half of 2026 as we complete dispositions and sales of partial interests.
    As of March 31, 2026:
    Our credit ratings from S&P Global Ratings and Moody’s Ratings were BBB+ and Baa1, respectively, which rank in the top
    15% among all publicly traded U.S. REITs.
    Significant liquidity of $4.17 billion, or 3.7x of our debt maturities through 2028.
    Only 9% of our total debt matures through 2028.
    10.0-year weighted-average remaining debt term, the longest among S&P 500 REITs.
    Total debt and preferred stock to gross assets of 31%.
    48
    Solid leasing of development and redevelopment space
    Leasing volume of 647,356 RSF during the three months ended March 31, 2026.
    Leasing of development and redevelopment space aggregating 117,935 RSF during the three months ended March 31,
    2026, up 135% from the prior five quarter average, excluding a build-to-suit lease executed in July 2025 with a long-
    standing multinational pharmaceutical tenant.
    From April 1, 2026 through the date of this report, we have executed leases and/or letters of intent aggregating
    276,188 RSF related to our development and redevelopment pipeline.
    72% of our leasing activity during the three months ended March 31, 2026 was generated from our existing tenant base.
    Three Months Ended
    March 31, 2026
    Leasing activity in RSF:
    Leasing of development and redevelopment space
    117,935
    Leasing of previously vacant space
    148,734
    Lease renewals and re-leasing of space
    380,687
    647,356
    Lease renewals and re-leasing of space:
    Rental rate increase
    (15.0)%
    Rental rate increase (cash basis)
    (15.8)%
    Excluding the impact of one lease aggregating 47,719 RSF at 480 Arsenal Street in our Cambridge/Inner Suburbs submarket,
    rental rates for renewed and re-leased space for the three months ended March 31, 2026 would have decreased by 10.1%
    and 9.1% (cash basis). The space at 480 Arsenal Street was re-leased to an entertainment studio user to accommodate their
    expansion needs and secure a long-term extension. In addition, the reorientation of this building layout provides flexibility to
    market the remaining available space to a broader range of user demand.
    Key operating metrics
    Total revenues of $671.0 million, down 11.5%, for the three months ended March 31, 2026, compared to $758.2 million for the
    three months ended March 31, 2025. Excluding dispositions completed after January 1, 2025, total revenues would have
    decreased by 5.1% for the three months ended March 31, 2026 compared to the three months ended March 31, 2025.
    Net operating income (cash basis) of $1.7 billion for the three months ended March 31, 2026, annualized, decreased by
    $300.6 million, or 15.2%, compared to the three months ended March 31, 2025, annualized.
    Change in net operating income (cash basis) reflects the impact of operating properties disposed of after January 1, 2025.
    Excluding these dispositions, net operating income (cash basis), annualized, for the three months ended March 31, 2026,
    would have decreased by 8.9%.
    Same property net operating income decreased by 11.9% and 11.7% (cash basis) for the three months ended March 31, 2026,
    compared to the three months ended March 31, 2025.
    The quarter-over-quarter decline was due to a decrease in same property occupancy, primarily driven by the previously
    disclosed 2026 key lease expirations aggregating 657,492 RSF that became vacant during the three months ended March
    31, 2026, with a weighted-average lease expiration date of January 2026, and by vacancy during the three months ended
    December 31, 2025 at one property aggregating 170,618 RSF at Alexandria Center® for Advanced Technologies – South
    San Francisco in our South San Francisco submarket. We expect our same property performance to improve in the
    second half of 2026, primarily due to changes in same property occupancy, including the anticipated delivery of 1.1 million
    RSF of vacant space that was leased but not yet delivered as of March 31, 2026, which has a weighted-average expected
    delivery date of approximately September 2026, and is expected to generate annual rental revenue of approximately $68
    million.
    Same properties average occupancy for the three months ended March 31, 2026 was 88.9%, compared to 94.0% average
    same properties occupancy for the three months ended March 31, 2025.
    Continued successful reduction and management of general and administrative expenses
    General and administrative expenses for the three months ended March 31, 2026 aggregated $34.7 million, which represents
    a decrease of $7.4 million, or 18%, compared to the quarterly average for 2024. For the trailing twelve months ended
    March 31, 2026, general and administrative expenses as a percentage of net operating income were 6.0%, approximately half
    the average of other S&P 500 REITs for 2023–2025.
    During the year ended December 31, 2025, we achieved general and administrative expense reduction of $51.3 million, or
    30%, compared to the year ended December 31, 2024, primarily as a result of cost-control and efficiency initiatives. Some of
    these cost savings were temporary, and we anticipate that approximately half of the cost reduction achieved in 2025 will
    continue in 2026.
    49
    Dividend strategy to share net cash flows from operating activities with stockholders while retaining a significant portion for reinvestment
    Common stock dividend declared of $0.72 per share for the three months ended March 31, 2026, consistent with the
    preceding quarter. The declared dividend per common share reflects our commitment to maintaining the strength of our
    balance sheet, enhancing financial flexibility, preserving liquidity, and sharing cash flows with our stockholders.
    Significant net cash provided by operating activities, as adjusted, retained for reinvestment aggregating $2.60 billion for the
    years ended December 31, 2022 through 2025 and the midpoint of our 2026 guidance range.
    Dividend yield of 6.2% as of March 31, 2026 and dividend payout ratio of 42% for the three months ended March 31, 2026.
    Ongoing execution of Alexandria’s capital recycling strategy
    We plan to continue funding a significant portion of our capital requirements for the year ending December 31, 2026 through
    dispositions of land, non-core assets, and core assets (primarily sales of partial interests).
    (dollars in millions)
    Sales Price
    %
    Completed and pending transactions subject to non-refundable deposits, signed letters of intent, and/or
    sale agreement negotiations as of the date of this report
    $151
    5%
    Identified and in process
    2,181
    75%
    Additional projected
    568
    20%
    2026 guidance midpoint for dispositions and sales of partial interests
    $2,900
    Occupancy and leasing progress on temporary vacancy
    Operating occupancy as of December 31, 2025
    90.9%
    Reduction in occupancy related to previously disclosed key lease expirations during the three months ended
    March 31, 2026
    (1.9)
    (1)
    Other changes in occupancy
    (1.3)
    (2)
    Operating occupancy as of March 31, 2026
    87.7
    Vacant space leased but not yet delivered
    3.2
    (3)
    Operating occupancy as of March 31, 2026, including vacant space leased but not yet delivered
    90.9%
    (1)Represents previously disclosed key lease expirations aggregating 657,492 RSF, with a weighted-average lease expiration date of January 2026 and prior annual rental
    revenue of approximately $41.6 million. These vacant spaces are currently 48% leased or under negotiation and the remaining 52% is being actively marketed for re-
    lease.
    (2)Includes i) 139,408 RSF, or 0.4%, resulting from spaces vacated by tenants winding down operations, which are being actively marketed for re-lease and ii) delivery of
    50,531 vacant RSF, or 0.2%, at our 10075 Barnes Canyon Road development project located at our SD Tech by Alexandria Megacampus.
    (3)Represents temporary vacancies aggregating 1.1 million RSF, primarily in the Greater Boston, San Francisco Bay Area, and Seattle markets, that are leased and
    expected to be occupied upon completion of building and/or tenant improvements. The weighted-average expected delivery date is approximately September 2026, with
    expected annual rental revenue of approximately $68 million.
    Key capital metrics as of or for the three months ended March 31, 2026
    $20.44 billion in total market capitalization.
    $7.92 billion in total equity capitalization.
    Non-real estate investments aggregating $1.54 billion:
    Unrealized gains presented in our consolidated balance sheet were $125.9 million, comprising gross unrealized gains and
    losses aggregating $191.5 million and $65.6 million, respectively.
    Investment loss of $4.6 million for the three months ended March 31, 2026 presented in our consolidated statement of
    operations consisted of $18.2 million of realized gains, $10.3 million of unrealized losses, and $12.4 million of impairment
    charges.
    50
    Key capital events
    In February 2026, we completed tender offers to repurchase an aggregate debt principal amount of $1.33 billion across a
    portion of our outstanding 4.00% Senior Notes due 2050, 3.00% Senior Notes due 2051, and 3.55% Senior Notes due 2052.
    Cash consideration paid was $952.2 million. In connection with the debt repurchase, we recognized a gain on early
    extinguishment of debt of approximately $366.4 million, including the write-off of unamortized debt issuance costs and other
    transaction-related costs.
    We funded the repurchases as follows:
    $750.0 million through the issuance of 5.25% unsecured senior notes due 2036; and
    Approximately $200 million through short-term borrowings under our commercial paper program, which will be repaid
    through planned dispositions and sales of partial interests included in our 2026 guidance.
    The repurchase reduced debt and improved leverage by approximately 0.2x.
    This transaction did not have a significant impact to our FFO per share diluted, as adjusted, interest expense, or fixed-
    charge coverage ratio.
    Following this transaction, our weighted-average remaining term of debt as of March 31, 2026 is 10.0 years, which
    continues to be the longest among S&P 500 REITs.
    In

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent insider activity

    Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 5 transactions across 3 insiders. Net: +26,500 shares, $1,113,674.

    Date Insider Role Action Shares Price Value
    2026-06-09 Binda Marc E CFO & Treasurer Sell -2,000 $54.00 -$108,000
    2026-05-06 MARCUS JOEL S Executive Chairman Buy +7,500 ×2 $46.34 $347,558
    2026-05-05 MARCUS JOEL S Executive Chairman Buy +7,500 ×3 $42.72 $320,416
    2026-05-04 MARCUS JOEL S Executive Chairman Buy +10,000 $41.02 $410,200
    2026-04-30 Thomas Gregory Calvin EVP - CTO Buy +3,500 $41.00 $143,500

    Source: SEC Form 4 filings.

    Next expected filings

    • ~2026-10-26 10-Q expected by 2026-11-11 (in 92 days)
    • ~2027-01-25 10-K expected by 2027-03-03 (in 183 days)
    • ~2027-04-26 10-Q expected by 2027-05-12 (in 274 days)
    • ~2027-07-20 10-Q expected by 2027-08-05 (in 359 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-07-09 8-K Material Agreement Entered; Material Financial Obligation
    • 2026-04-27 10-Q Quarterly Report
    • 2026-04-27 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-02-25 8-K Material Agreement Entered; Material Financial Obligation; Financial Statements and Exhibits
    • 2026-02-12 8-K Other Events; Financial Statements and Exhibits
    • 2026-01-26 10-K Annual Report
    • 2026-01-26 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-12 8-K Officer/Director Change
    • 2025-12-08 8-K Officer/Director Change; Other Events; Financial Statements and Exhibits
    • 2025-10-27 10-Q Quarterly Report
    • 2025-10-27 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-07-21 10-Q Quarterly Report
    • 2025-07-21 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-05-15 8-K Officer/Director Change; Shareholder Vote Results; Financial Statements and Exhibits
    • 2025-04-28 10-Q Quarterly Report